FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904438991> ?p ?o ?g. }

• W2904438991 endingPage "e318" @default.
• W2904438991 startingPage "e306" @default.
• W2904438991 abstract "Background Single-agent gemcitabine is a moderately effective compound in metastatic breast cancer (mBC) treatment. Carboplatin is frequently used in addition to gemcitabine to improve tumor responses, but with an unclear effect on survival outcomes. In this study we evaluated the antitumor efficacy and safety profiles of gemcitabine and carboplatin-gemcitabine in mBC patients. Patients and Methods We retrospectively collected data on patients treated between April 2012 and February 2018 with gemcitabine 800 mg/m2or carboplatin at an area under the curve of 2 with gemcitabine 800 mg/m2, given on days 1 and 8 every 21 days. We compared progression-free survival (PFS), objective response rate (ORR), overall survival, and incidence of adverse events (AEs) in the 2 cohorts. Results Of 163 consecutive patients who met the inclusion criteria, 75 received gemcitabine and 88 carboplatin-gemcitabine. Patients in the combination cohort had received a lower number of previous chemotherapy lines (2 vs. 3), and were less likely to have received carboplatin (9 patients [10%] vs. 34 patients [45%]; P < .0001). We found no PFS differences in carboplatin-gemcitabine and gemcitabine cohorts (4.24 vs. 4.61 months; adjusted hazard ratio, 0.98; P = .92), whereas the combination was associated with a trend toward higher ORR (18 patients [20.4%] vs. 8 patients [10.6%]; P = .089) and with significantly higher incidence of Grade 3/4 neutropenia (30 patients [34%] vs. 5 patients [6.6%]; P < .0001). Conclusion Using carboplatin in addition to gemcitabine is associated with more hematologic AEs but not with better PFS. Although single-agent gemcitabine remains a treatment option for heavily pretreated mBC patients, finding biomarkers of response to platinum salts might help to identify patients more likely to benefit from carboplatin-gemcitabine." @default.
• W2904438991 created "2018-12-22" @default.
• W2904438991 creator A5008973511 @default.
• W2904438991 creator A5009158742 @default.
• W2904438991 creator A5009935310 @default.
• W2904438991 creator A5012144681 @default.
• W2904438991 creator A5012466586 @default.
• W2904438991 creator A5013009758 @default.
• W2904438991 creator A5020943144 @default.
• W2904438991 creator A5025221164 @default.
• W2904438991 creator A5038576978 @default.
• W2904438991 creator A5044033864 @default.
• W2904438991 creator A5048977427 @default.
• W2904438991 creator A5053009011 @default.
• W2904438991 creator A5081150854 @default.
• W2904438991 creator A5081344507 @default.
• W2904438991 creator A5088042472 @default.
• W2904438991 date "2019-04-01" @default.
• W2904438991 modified "2023-10-17" @default.
• W2904438991 title "Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles" @default.
• W2904438991 cites W1701849548 @default.
• W2904438991 cites W1812067939 @default.
• W2904438991 cites W1871271676 @default.
• W2904438991 cites W1971473564 @default.
• W2904438991 cites W1972362283 @default.
• W2904438991 cites W1976487179 @default.
• W2904438991 cites W1977628815 @default.
• W2904438991 cites W1987053256 @default.
• W2904438991 cites W1990481468 @default.
• W2904438991 cites W1991819791 @default.
• W2904438991 cites W1997838307 @default.
• W2904438991 cites W2002970629 @default.
• W2904438991 cites W2009930501 @default.
• W2904438991 cites W2013246214 @default.
• W2904438991 cites W2019607817 @default.
• W2904438991 cites W2025135843 @default.
• W2904438991 cites W2030566540 @default.
• W2904438991 cites W2045316633 @default.
• W2904438991 cites W2068455253 @default.
• W2904438991 cites W2068532424 @default.
• W2904438991 cites W2093051851 @default.
• W2904438991 cites W2119609398 @default.
• W2904438991 cites W2127152525 @default.
• W2904438991 cites W2137545466 @default.
• W2904438991 cites W2142226415 @default.
• W2904438991 cites W2144727586 @default.
• W2904438991 cites W2153072711 @default.
• W2904438991 cites W2178665864 @default.
• W2904438991 cites W2279656465 @default.
• W2904438991 cites W2539417294 @default.
• W2904438991 cites W2626533911 @default.
• W2904438991 cites W2758315038 @default.
• W2904438991 cites W2801956643 @default.
• W2904438991 cites W2806428922 @default.
• W2904438991 cites W2806830990 @default.
• W2904438991 cites W4237654342 @default.
• W2904438991 cites W838231463 @default.
• W2904438991 doi "https://doi.org/10.1016/j.clbc.2018.12.004" @default.
• W2904438991 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30635175" @default.
• W2904438991 hasPublicationYear "2019" @default.
• W2904438991 type Work @default.
• W2904438991 sameAs 2904438991 @default.
• W2904438991 citedByCount "13" @default.
• W2904438991 countsByYear W29044389912019 @default.
• W2904438991 countsByYear W29044389912020 @default.
• W2904438991 countsByYear W29044389912021 @default.
• W2904438991 countsByYear W29044389912022 @default.
• W2904438991 countsByYear W29044389912023 @default.
• W2904438991 crossrefType "journal-article" @default.
• W2904438991 hasAuthorship W2904438991A5008973511 @default.
• W2904438991 hasAuthorship W2904438991A5009158742 @default.
• W2904438991 hasAuthorship W2904438991A5009935310 @default.
• W2904438991 hasAuthorship W2904438991A5012144681 @default.
• W2904438991 hasAuthorship W2904438991A5012466586 @default.
• W2904438991 hasAuthorship W2904438991A5013009758 @default.
• W2904438991 hasAuthorship W2904438991A5020943144 @default.
• W2904438991 hasAuthorship W2904438991A5025221164 @default.
• W2904438991 hasAuthorship W2904438991A5038576978 @default.
• W2904438991 hasAuthorship W2904438991A5044033864 @default.
• W2904438991 hasAuthorship W2904438991A5048977427 @default.
• W2904438991 hasAuthorship W2904438991A5053009011 @default.
• W2904438991 hasAuthorship W2904438991A5081150854 @default.
• W2904438991 hasAuthorship W2904438991A5081344507 @default.
• W2904438991 hasAuthorship W2904438991A5088042472 @default.
• W2904438991 hasConcept C121608353 @default.
• W2904438991 hasConcept C126322002 @default.
• W2904438991 hasConcept C143998085 @default.
• W2904438991 hasConcept C207103383 @default.
• W2904438991 hasConcept C2776694085 @default.
• W2904438991 hasConcept C2777063308 @default.
• W2904438991 hasConcept C2778239845 @default.
• W2904438991 hasConcept C2780258809 @default.
• W2904438991 hasConcept C2781451048 @default.
• W2904438991 hasConcept C44249647 @default.
• W2904438991 hasConcept C530470458 @default.
• W2904438991 hasConcept C71924100 @default.
• W2904438991 hasConceptScore W2904438991C121608353 @default.
• W2904438991 hasConceptScore W2904438991C126322002 @default.

• next